Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Veracyte reported $1.08B in Equity Capital and Reserves for its fiscal quarter ending in March of 2023.

Equity Capital And Reserves Change
Agenus AGEN:US USD -58536000 2.74M
Agilent A:US USD 5.78B 172M
Anika Therapeutics ANIK:US USD 277.59M 7.98M
Arrowhead Research ARWR:US USD 446.77M 69.73M
Bruker BRKR:US USD 1.2B 85M
Exact Sciences EXAS:US USD 3.06B 14.55M
Heron Therapeutics HRTX:US USD -11429000 25M
Illumina ILMN:US USD 6.69B 94M
Immunogen IMGN:US USD 121.92M 33.91M
Intrexon XON:US USD 184.13M 57.87M
Karyopharm Therapeutics KPTI:US USD -45174000 28.52M
Laboratory Of America LH:US USD 10.34B 244.9M
Ligand Pharmaceuticals LGND:US USD 646.32M 48.83M
Myriad Genetics MYGN:US USD 835.2M 50.6M
Rigel Pharmaceuticals RIGL:US USD -24257000 10.64M
Roche Holding ROG:VX CHF 27.99B 2.8B
Sangamo BioSciences SGMO:US USD 335.61M 40.65M
Siemens SIE:GR EUR 45.2B 513M
Sonic Healthcare SHL:AU AUD 7.39B 120.72M
Thermo Fisher Scientific TMO:US USD 42.31B 1.72B
Veracyte VCYT:US USD 1.08B 6.06M
Waters WAT:US USD 599.82M 95.34M